Just a theory, absolutely no proof whatsoever -
Many health stocks have continued on their merry way higher, even if there's been an overall falling away of the overall market. IMO the investors/speculators etc that have made (and probably are continuing to make) money from such investments have combed the health sector for likely future candidates - and obviously EBR fits right into that category.
It remains a highly discounted opportunity, just counting down the days towards FDA submission. At some point it will likely go through a significant rerating, but thats probably still some time away, lnowing that the FDA submission is anticipated for 3Q 24.
General Investor Information EBR Systems, page-246
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $346.6M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.12 | $152.8K | 134.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1875 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 23619 | 1 |
View Market Depth
| Last trade - 15.54pm 31/07/2024 (20 minute delay) ? |
| EBR (ASX) Chart |